Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04011306Not ApplicableUnknown

A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns

Role: lead

NCT03948360Not ApplicableUnknown

Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds

Role: lead

NCT02939274Phase 2Unknown

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

Role: lead

NCT01262716Completed

A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer

Role: lead

All 4 trials loaded